Filing Details
- Accession Number:
- 0001179929-17-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-11 18:02:15
- Reporting Period:
- 2017-05-09
- Filing Date:
- 2017-05-11
- Accepted Time:
- 2017-05-11 18:02:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1179929 | Molina Healthcare Inc | MOH | Hospital & Medical Service Plans (6324) | 134204626 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1305822 | Terry Bayer | 300 University Avenue, Suite 100 Sacramento CA 95825 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-05-09 | 7,952 | $67.79 | 122,462 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-05-10 | 17,096 | $66.97 | 105,366 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-05-11 | 9,673 | $66.71 | 95,693 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 15, 2017.
- Represents the weighted average selling price with a selling price range between $67.29 and $68.30.
- Represents the weighted average selling price with a selling price range between $66.74 and $67.30.
- Represents the weighted average selling price with a selling price range between $66.12 and $68.15.
- The shares vest as follows: (i) 16,033 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (ii) 5,154 shares shall vest based on the Company's 2017 after tax profit margin; (iii) 5,154 shares shall vest based on the Company's 2018 after tax profit margin; (iv) 5,154 shares shall vest based upon the Company's 2017 STARS ratings; (v) 7,731 shares shall vest upon the Company's achievement of certain business development targets; (vi) 10,309 shares shall vest in two increments on each of March 7, 2018 and March 7, 2019; continued
- (vii) 2,865 shares shall vest based on the Company's 2017 annual premium revenue achievement; (viii) 2,865 shares shall vest based on the Company's 2017 net profit margin achievement; (ix) 2,865 shares shall vest based on pre-tax income in fiscal year 2017; (x) 2,865 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xi) 2,866 shares shall vest on April 1, 2018; the remainder of the shares are vested.